Matches in SemOpenAlex for { <https://semopenalex.org/work/W3119679304> ?p ?o ?g. }
Showing items 1 to 99 of
99
with 100 items per page.
- W3119679304 endingPage "7796" @default.
- W3119679304 startingPage "7782" @default.
- W3119679304 abstract "BACKGROUND Cancer/testis antigens (CTAs) are attractive therapeutic targets for tumor immunotherapy due to their restrictive expression in normal testis but excessive in majority of tumor types. ACTL8, CTCFL, OIP5 and XAGE3 are members of the CTAs family. Currently, the data of ACTL8, CTCFL, OIP5 and XAGE3 expression in glioma is limited. Methods: ACTL8, CTCFL, OIP5 and XAGE3 mRAN and protein expressions were detected in 108 glioma samples by Reverse Transcriptase-PCR (RT-PCR) and immunohistochemistry and the correlations between their expressions and clinical indexes were analyzed. Furthermore, their clinical significance on glioma prognosis was determined by follow-up data. Results: The mRNA positive rate of ACTL8, CTCFL, OIP5 and XAGE3 was 15.74% (17/108), 22.22% (24/108), 13.89% (15/108) and 37.96% (41/108), respectively. At least one CTA mRNA was expressed by 61.11% of glioma tissues, while 2 or more by 29.63%. For protein expression, the positive rate of them was 21.30% (23/108), 34.26% (37/108), 19.44% (21/108) and 23.15% (25/108), respectively. At least one CTA protein was expressed by 58.33% of glioma tissues and 2 or more by 29.63%. Although there were no correlations between their mRNA expressions and clinicopathological parameters, the protein expression of ACTL8, OIP5 and XAGE3 was positively correlated with KPS; while the ACTL8 protein was correlated with gender, and OIP5 protein with gender and WHO grade. Kaplan-Meier analysis revealed a significant negative correlation between the CTCFL protein expression, combined ACTL8 and/or CTCFL protein expression and survival. Conclusions: The results suggest that the cohort of glioma does express ACTL8, CTCFL, OIP5 and XAGE3 at both mRNA and protein levels indicating glioma is CTAs-rich tumors. CTCFL protein and the combined ACTL8 and/or CTCFL protein might act as poor prognostic markers for glioma and as potential ideal combined antigens for glioma immunotherapy." @default.
- W3119679304 created "2021-01-18" @default.
- W3119679304 creator A5000844607 @default.
- W3119679304 creator A5022173597 @default.
- W3119679304 creator A5022228815 @default.
- W3119679304 creator A5022256556 @default.
- W3119679304 creator A5030377129 @default.
- W3119679304 creator A5039614579 @default.
- W3119679304 creator A5055565843 @default.
- W3119679304 creator A5070019911 @default.
- W3119679304 creator A5073578977 @default.
- W3119679304 creator A5083212319 @default.
- W3119679304 creator A5087067670 @default.
- W3119679304 creator A5089439923 @default.
- W3119679304 creator A5090178829 @default.
- W3119679304 date "2020-12-15" @default.
- W3119679304 modified "2023-09-27" @default.
- W3119679304 title "Expression profile of ACTL8, CTCFL, OIP5 and XAGE3 in glioma and their prognostic significance: a retrospective clinical study." @default.
- W3119679304 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7791493" @default.
- W3119679304 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33437360" @default.
- W3119679304 hasPublicationYear "2020" @default.
- W3119679304 type Work @default.
- W3119679304 sameAs 3119679304 @default.
- W3119679304 citedByCount "2" @default.
- W3119679304 countsByYear W31196793042022 @default.
- W3119679304 countsByYear W31196793042023 @default.
- W3119679304 crossrefType "journal-article" @default.
- W3119679304 hasAuthorship W3119679304A5000844607 @default.
- W3119679304 hasAuthorship W3119679304A5022173597 @default.
- W3119679304 hasAuthorship W3119679304A5022228815 @default.
- W3119679304 hasAuthorship W3119679304A5022256556 @default.
- W3119679304 hasAuthorship W3119679304A5030377129 @default.
- W3119679304 hasAuthorship W3119679304A5039614579 @default.
- W3119679304 hasAuthorship W3119679304A5055565843 @default.
- W3119679304 hasAuthorship W3119679304A5070019911 @default.
- W3119679304 hasAuthorship W3119679304A5073578977 @default.
- W3119679304 hasAuthorship W3119679304A5083212319 @default.
- W3119679304 hasAuthorship W3119679304A5087067670 @default.
- W3119679304 hasAuthorship W3119679304A5089439923 @default.
- W3119679304 hasAuthorship W3119679304A5090178829 @default.
- W3119679304 hasConcept C104317684 @default.
- W3119679304 hasConcept C105580179 @default.
- W3119679304 hasConcept C121608353 @default.
- W3119679304 hasConcept C126322002 @default.
- W3119679304 hasConcept C142724271 @default.
- W3119679304 hasConcept C143998085 @default.
- W3119679304 hasConcept C204232928 @default.
- W3119679304 hasConcept C2777701055 @default.
- W3119679304 hasConcept C2778227246 @default.
- W3119679304 hasConcept C502942594 @default.
- W3119679304 hasConcept C55493867 @default.
- W3119679304 hasConcept C63363279 @default.
- W3119679304 hasConcept C6856738 @default.
- W3119679304 hasConcept C71924100 @default.
- W3119679304 hasConcept C86803240 @default.
- W3119679304 hasConceptScore W3119679304C104317684 @default.
- W3119679304 hasConceptScore W3119679304C105580179 @default.
- W3119679304 hasConceptScore W3119679304C121608353 @default.
- W3119679304 hasConceptScore W3119679304C126322002 @default.
- W3119679304 hasConceptScore W3119679304C142724271 @default.
- W3119679304 hasConceptScore W3119679304C143998085 @default.
- W3119679304 hasConceptScore W3119679304C204232928 @default.
- W3119679304 hasConceptScore W3119679304C2777701055 @default.
- W3119679304 hasConceptScore W3119679304C2778227246 @default.
- W3119679304 hasConceptScore W3119679304C502942594 @default.
- W3119679304 hasConceptScore W3119679304C55493867 @default.
- W3119679304 hasConceptScore W3119679304C63363279 @default.
- W3119679304 hasConceptScore W3119679304C6856738 @default.
- W3119679304 hasConceptScore W3119679304C71924100 @default.
- W3119679304 hasConceptScore W3119679304C86803240 @default.
- W3119679304 hasIssue "12" @default.
- W3119679304 hasOpenAccess W3119679304 @default.
- W3119679304 hasRelatedWork W1499538703 @default.
- W3119679304 hasRelatedWork W1525330301 @default.
- W3119679304 hasRelatedWork W1994320377 @default.
- W3119679304 hasRelatedWork W2001264908 @default.
- W3119679304 hasRelatedWork W2044127996 @default.
- W3119679304 hasRelatedWork W2051047807 @default.
- W3119679304 hasRelatedWork W2075580956 @default.
- W3119679304 hasRelatedWork W2314457859 @default.
- W3119679304 hasRelatedWork W2351746970 @default.
- W3119679304 hasRelatedWork W2352154282 @default.
- W3119679304 hasRelatedWork W2363614799 @default.
- W3119679304 hasRelatedWork W2366536444 @default.
- W3119679304 hasRelatedWork W2394262666 @default.
- W3119679304 hasRelatedWork W2400607900 @default.
- W3119679304 hasRelatedWork W2408088858 @default.
- W3119679304 hasRelatedWork W2737229932 @default.
- W3119679304 hasRelatedWork W2768323545 @default.
- W3119679304 hasRelatedWork W2887863117 @default.
- W3119679304 hasRelatedWork W3099292573 @default.
- W3119679304 hasRelatedWork W2292106106 @default.
- W3119679304 hasVolume "12" @default.
- W3119679304 isParatext "false" @default.
- W3119679304 isRetracted "false" @default.
- W3119679304 magId "3119679304" @default.
- W3119679304 workType "article" @default.